Literature DB >> 15319043

Caring for children with asthma through teleconsultation: "ECHO-Pac, The Electronic Children's Hospital of the Pacific".

Francis Malone1, Charles W Callahan, Debora S Chan, Scott Sheets, Donald A Person.   

Abstract

A Web-based store-and-forward teleconsultation asthma management system was implemented to provide subspecialty asthma care to military children with asthma living in the Western Pacific. Seven children with moderate to severe asthma (mean age 11.9 +/- 3.7 years) were followed for 1 year by their primary care provider (PCM) using a Web-based asthma pathway, with regular pediatric pulmonary teleconsults to Tripler Army Medical Center. Therapeutic monitoring included MPEG video recording of patient using metered-dose inhaler (MDI) technique submitted to the pulmonologist at specified intervals. Utilization of services for unscheduled asthma-related visits was monitored. PCMs were surveyed regarding their asthma practice before and after the intervention. Data were analyzed using Student's t test for continuous variables and Wilcoxon signed-rank or chi-square for noncontinuous variables. Therapeutic adherence was evidenced by improved inhaler technique in all patients. There were fewer ED visits for asthma (3.85 +/- 5.14, range 0-15 vs. 0 visits, p < 0.05) and fewer unscheduled acute clinic visits (1.57 +/- 1.27, range 0-4 vs. 0.286 +/- 0.48, p < 0.05) in the study year versus the preceding year. There were two hospitalizations in the year prior to the study; however, no patients were hospitalized during the study PCM use of an asthma action plan increased from 24% to 73% (p < 0.01) and provision of asthma education increased from 18% to 73%, (p < 0.01). However, PCMs reported that they were not more likely to watch their patient's MDI technique themselves (29% vs. 45%) nor order or interpret spirometry on their patients (12 vs. 18%). In this project, children with asthma followed by teleconsultation had improved outcomes. Store-and-forward teleconsultation can be used to follow children with chronic disease such as asthma over time.

Entities:  

Mesh:

Year:  2004        PMID: 15319043     DOI: 10.1089/tmj.2004.10.138

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  6 in total

1.  Increasing hospitalizations in inflammatory bowel disease among children in the United States, 1988-2011.

Authors:  Kelly C Sandberg; Matthew M Davis; Achamyeleh Gebremariam; Jeremy Adler
Journal:  Inflamm Bowel Dis       Date:  2014-10       Impact factor: 5.325

2.  Association between inhaler technique and confidence among hospitalized children with asthma.

Authors:  Henry K Litt; Valerie G Press; Ashley Hull; Michelle Siros; Viridiana Luna; Anna Volerman
Journal:  Respir Med       Date:  2020-10-09       Impact factor: 3.415

Review 3.  The use of behavior change theory in Internet-based asthma self-management interventions: a systematic review.

Authors:  Mustafa Al-Durra; Monika-Bianca Torio; Joseph A Cafazzo
Journal:  J Med Internet Res       Date:  2015-04-02       Impact factor: 5.428

4.  Barriers and facilitators for implementation of electronic consultations (eConsult) to enhance access to specialist care: a scoping review.

Authors:  Mohamed A Osman; Kara Schick-Makaroff; Stephanie Thompson; Liza Bialy; Robin Featherstone; Julia Kurzawa; Deenaz Zaidi; Ikechi Okpechi; Syed Habib; Soroush Shojai; Kailash Jindal; Branko Braam; Erin Keely; Clare Liddy; Braden Manns; Marcello Tonelli; Brenda Hemmelgarn; Scott Klarenbach; Aminu K Bello
Journal:  BMJ Glob Health       Date:  2019-09-13

5.  Asynchronous telehealth: a scoping review of analytic studies.

Authors:  Amol Deshpande; Shariq Khoja; Julio Lorca; Ann McKibbon; Carlos Rizo; Donald Husereau; Alejandro R Jadad
Journal:  Open Med       Date:  2009-06-02

Review 6.  Telehealthcare for asthma.

Authors:  Susannah McLean; David Chandler; Ulugbek Nurmatov; Joseph Liu; Claudia Pagliari; Josip Car; Aziz Sheikh
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.